Malaria Molecular Diagnostic Network 

The University of Washington MMDL is working with partners to bring together a network of laboratories that perform molecular detection of Plasmodium parasites in support of malaria clinical trials and epidemiology studies.  The goal is generate a collaborative team where high-quality, high-throughput molecular testing can be used to safely and efficiently advance promising drugs, monoclonal antibodies, and vaccines and inform malaria control and elimination efforts. If your laboratory is interested in hearing more about the MMDN, please contact Dr. Murphy (murphysc (at) uw.edu). 

Last updated: July 1, 2023